Rhenman & Partners Asset Management’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.44M Sell
56,263
-90,000
-62% -$9.23M 0.67% 54
2025
Q4
$15.5M Buy
146,263
+26,863
+22% +$3.11M 1.45% 28
2025
Q3
$15.2M Sell
119,400
-17,000
-12% -$2.02M 1.68% 22
2025
Q2
$16.7M Buy
136,400
+99,000
+265% +$11.3M 2.11% 16
2025
Q1
$3.79M Sell
37,400
-18,600
-33% -$1.82M 0.44% 53
2024
Q4
$5.17M Sell
56,000
-5,000
-8% -$491K 0.53% 56
2024
Q3
$5.9M Buy
61,000
+1,000
+2% +$89.9K 0.48% 62
2024
Q2
$5.15M Buy
60,000
+31,000
+107% +$2.6M 0.49% 54
2024
Q1
$2.39M Buy
+29,000
New +$2.12M 0.23% 71

Other funds holding EHC

Rhenman & Partners Asset Management's EHC Position: Q1 2026 in Review

Rhenman & Partners Asset Management reduced its Encompass Health (EHC) stake by 62% in Q1 2026, selling an estimated $9.23M and leaving 56,263 shares worth $5.44M. The position accounts for 0.67% of the portfolio, ranked #54.

Rhenman & Partners Asset Management first reported a position in EHC in Q1 2024 and has held it in 9 quarters since. The position peaked at $16.7M in Q2 2025. 577 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

  • Rhenman & Partners Asset Management held 56,263 shares of Encompass Health worth $5.44M as of Q1 2026.
  • Rhenman & Partners Asset Management sold 90,000 Encompass Health shares in Q1 2026, an estimated $9.23M.
  • Encompass Health made up 0.67% of Rhenman & Partners Asset Management's portfolio in Q1 2026, its #54 holding.
  • Rhenman & Partners Asset Management first reported a position in Encompass Health in Q1 2024 and has held it in 9 quarters since.
  • Rhenman & Partners Asset Management's Encompass Health position peaked at $16.7M in Q2 2025.
  • 577 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Rhenman & Partners Asset Management's 13F filing for Q1 2026, filed 14 May 2026.